France Blood Banking Market Future Horizons and Growth Strategies, 2019-2023: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

The new strategic analysis is prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.  

Rationale

During the next five years, the French blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. 

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations

- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

The report explores future marketing and technological trends in the France; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG,  C3),
Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,
Hepatitis (HAV NAT, HBV NAT, HBs Ag,  
Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT,
Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates of leading
suppliers of blood banking of reagents
and instruments, by individual product.

Competitive Assessments

Strategic assessments of major suppliers and
emerging market entrants, including their sales,
product portfolios, marketing tactics, and new
products in R&D.

Market Segmentation Analysis

- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers.

- Test volume and sales forecasts for over 40
blood banking tests, including NAT, by market segment:

- Blood Centers
- Hospitals
- Commercial/Private Laboratories

Current and Emerging Products

- Analysis of current and emerging blood banking tests.

- Review of automated and semi-automated
analyzers, including their operating
characteristics, features, and selling prices.

Technology Review

- Assessment of current and emerging technologies,
and their potential applications for the blood banking market.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Contains 430 pages and 43 tables

I. Introduction

II. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious
Disease Screening Tests
1. Blood Typing and Grouping Tests
a. ABO
b. Antibody Panels
c. Antibody Screening
d. Antigen Typing
e. Antiglobulin Test
f. Crossmatch
g. HLA Typing
h. Rh
i. Other Blood Groups
2. Blood Group Genotyping
a. PCR
b. PCR-RFLP
c. AS-PCR or PCR-SSP
d. Multiplex PCR
e. Real Time PCR
f. Sanger DNA Sequencing
g. Pyrosequencing
b. Microarrays
- BeadChip Array
- BloodChip
- Genome Lab SNP Stream
- Fluidic Microarray Systems
- TaqMan OpenArray
- MALDI-TOF-MS
- Mini-Sequencing
3. Infectious Disease Screening Tests
a. AIDS
- Structure and Composition
- Classification
- Origin of AIDS
- Animal Lentivirus Systems
- Virus Receptors
(continued)
- HIV Infections in Humans
-Pathogenesis & Pathology
-Overview of Course of HIV Infection
- CD4T Lymphocytes and Memory Cells
- Monocytes and Macrophages
- Lymphoid Organs
- Neural Cells
- Viral Coinfections
-Clinical Findings
- Plasma Viral Load
- Pediactric AIDS
-Neurologic Disease
-Opportunistic Infections
-Protozoa
-Fungi
-Bacteria
- Viruses
- Cancer
- Immunity
- Laboratory Diagnosis
-Virus Isolation
-Serology
-Detection of Viral Nucleic Acid or Antigens
- Epidemiology
-Worldwide Spread of AIDS
-United States
-Routes of Transmission
- Prevention, Treatment, And Control
-Antiviral Drugs
-Vaccines Against HIV
- Transmission of HIV in Blood Products
- HIV Transmission in Transplant and
Artificial Insemination Recipients
- Diagnostic Tests
- Enzyme Immunoassay Interpretation
- Specificity, Sensitivity, and Predictive
Value of Enzyme Immunoassay
- Competition Assays
- Western Blot Technique
- Immuno-Fluorescence Assay (IFA)
- Radioimmunoprecipitation
- HIV-1/HIV-2 Combination Testing
(continued)
- Methods of HIV-Antigen Detection
- Antigen Assays and Blood Screening
- Urine Tests
- DNA Probes
- Overview
- Quantitative Polymerase Chain Reaction
- In Situ PCR
- Needed Improvements
- Viral Load/Drug Resistance Testing
- Genotype and Phenotype Testing
- Blood Banking Considerations
b. Hepatitis
- Hepatitis A
- Hepatitis B
-Structure and Composition
-Replication of Hepatitis B Virus
- Hepatitis C
- Hepatitis D (Delta Hepatitis)
- Hepatitis E
- Hepatitis G
- Hepatitis Virus Infections In Humans
-Pathology
- Clinical Findings
- Laboratory Features
-Hepatitis A
-Hepatitis B
-Hepatitis C
-Hepatitis D
-Hepatitis E
- Virus-Host Immune Reactions
- Epidemiology
-Hepatitis A
-Hepatitis B
-Hepatitis C
-Hepatitis D (Delta Agent)
- Vaccines and Drugs
c. Cytomegalovirus
- Background
- Chorioretinitis
- Gastrointestinal
(continued)
- Central Nervous System Disease
- Diagnostic Tests
- Vaccines and Drugs
d. Syphilis
- Background
- Diagnostic Tests
- Vaccines and Drugs
e. West Nile Virus
- Background
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
f. Parvovirus B19
- Microbiology
- Epidemiology
- Clinical Syndromes
-Erythema Infectiosum Slapped (cheek)
-Adult Polyarthropathy
-Transient Aplastic Crisis
-Transient Pancytopenia
-Red Cell Aplasia in the Immunocompromised
-Perinatal Infections
- Diagnosis
- Treatment
g. Creutzfeldt-Jakobs Disease
- Background
- Transmission
- Diagnostic Tests
- Major Commercial and Academic Players
-Bayer
-Disease Sciences/BioTec Global
-Imperial College School of Medicine
-Ortho-Clinical Diagnostics
-Pall
-ProMetic Life Sciences
-Proteome Sciences/Idexx
-Q-One Biotech
-Serono
-U.S. Agricultural Research Service
(continued)
- Drugs
- Vaccines
h. Malaria
i. Chagas Disease
j. Babesiosis
4. Pathogen Reduction
5. Leukocyte Reduction
- Background
- Methods
B. Instrumentation Review: Operating Characteristics,
Features and Selling Prices of Leading Automated
and Semiautomated Analyzers Manufactured by:
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- BioMerieux
- Cepheid
- Curtis Unyvero
- Gen-Probe/Hologic
- GenMark
- Grifols
- HTG
- Immucor
- Life Technologies
- Nanosphere
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Sarstedt
- Siemens
- Tecan
C. Major in Vitro Diagnostic Technologies
And Their Potential Applications
1. Molecular Diagnostics
a. Overview
b. NAT
2. Monoclonal and Polyclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Chemiluminescence
(continued)
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
4. Microtitration Plates
5. IT and Automation
6. Lasers
7. Robotics
8. Synthetic Red Cell Substitutes
9. Genetically Engineered Blood Components
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrands Factor
g. Fibrinogen
h. t-PA
10. Blood Preservation
11. Autologous Blood Transfusion/Freezing
III. France
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier
Sales and Market Shares for Blood Typing, Grouping
and Infectious Disease Screening Tests
(continued)
IV. Major Product Development Opportunities
A. Molecular Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
VII. Competitive Assessments
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- CellMark Forensics/LabCorp
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Immucor
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens
- Tecan
- Thermo Fisher

List Of Tables

Major Companies Developing or Marketing
Blood Typing and Grouping Tests
Major Companies Developing or Marketing
HLA Typing Tests
Major Companies Developing or Marketing
AIDS Tests
Major Companies Developing or Marketing
Hepatitis Tests
Major Companies Developing or Marketing
CMV Tests
Major Companies Developing or Marketing
Syphilis Tests
Major Companies Developing or Marketing
Blood Bank Analyzers
Executive Summary Table: France, Total Blood Bank
Test Volume and Reagent Sales Forecast
By Test Category
France, Facilities Performing Blood
Bank Tests by Market Segment
France, Hospital Laboratories Performing
Blood Bank Tests by Bed Size
France, Commercial/Private Laboratories
Performing Blood Bank Tests
By Annual Test Volume
France, All Market Segments Blood Typing
And Grouping Test Volume Forecast
by Market Segment
France, All Market Segments Blood Typing
And Grouping Test Volume Forecast
(continued)
France, Hospital Laboratories Blood
Typing and Grouping Test Volume Forecast
France, Blood Banks Blood Typing
And Grouping Test Volume Forecast
France, Commercial/Private Laboratories
Blood Typing and Grouping Test Volume Forecast
France, All Market Segments Infectious
Disease Screening Test Volume Forecast
By Market Segment
France, All Market Segments Infectious
Disease Screening Test Volume Forecast
France, Blood Banks Infectious Disease
Screening Test Volume Forecast
France, Commercial/Private Laboratories
Infectious Disease Screening Test Volume Forecast
France, Hospital Laboratories Infectious
Disease Screening Test Volume Forecast
France, All Market Segments Blood Typing
And Grouping Reagent Market Forecast
By Market Segment
France, All Market Segments Blood Typing
And Grouping Reagent Market Forecast
By Major Test
France, Hospital Laboratories Blood
Typing and Grouping Reagent Market Forecast
By Major
France, Blood Banks Blood Typing and
Grouping Reagent Market Forecast
by Major Test
(continued)
France, Commercial/Private Laboratories
Blood Typing and Grouping Reagent Market Forecast
By Major Test
France, All Market Segments Infectious
Disease Screening Reagent Market Forecast
By Market Segment
France, All Market Segments Infectious
Disease Screening Reagent Market Forecast
By Test
France, Blood Banks Infectious Disease
Screening Reagent Market Forecast by Test
France, Commercial/Private Laboratories
Infectious Disease Screening Reagent Market Forecast
By Test
France, Hospital Laboratories Infectious
Disease Screening Reagent Market Forecast by Test
France, Major Suppliers of Blood Typing
And Grouping Reagents Estimated Sales
And Market Shares
France, HIV/HTLV Blood Screening Market,
Reagent Sales by Major Supplier
France, Hepatitis Blood Screening Market,
Reagent Sales by Major Supplier
France, HIV/Hepatitis NAT Screening Market
Reagent Sales by Major Supplier
France, CMV Blood Screening Market,
Reagent Sales By Major Supplier
France, Syphilis Blood Screening Market,
Reagent Sales By Major Supplier

Fill The Form For Sample Request

Full Name *

Business Email *

E-mail *

Country * Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available